Atrium Therapeutics Inc (RNA) Directors and Executive Officers - CSIMarket
CSIMarket
 
Atrium Therapeutics Inc   (NASDAQ: RNA)

Atrium Therapeutics Inc

Officers & Directors


Edward Kaye
Director

Arthur A. Levin
Director

Sarah Boyce
President and Chief Executive Officer

BDO USA, P.C.
San Diego, California - Served as the Company s auditor since

Troy Wilson
Chair of the Board of Directors

Carsten Boess
Director

Noreen Henig
Director

Tamar Thompson
Director

Jean Kim
Director

Michael F. MacLean
Chief Financial and Chief Business Officer ,

Atrium Therapeutics Inc currently has 511 employees.






RNA Management Effectiveness RNA Revenue per Employee RNA Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.